Australian IVD rules delayed - but concerns remain over costs & GHTF classifications
This article was originally published in Clinica
Executive Summary
The deadline for implementing Australia's new IVD regulatory framework has been delayed indefinitely and will cause further inconvenience to domestic companies. However, the Medical Industry Association of Australia (MIAA) is more concerned about the cost, to local and import business, of the final framework.